PDPatrycja Doroz

Patrycja Doroz

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Patrycja Doroz has a total of 9 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Barriers to dental treatment for patients on the autism spectrum disorder

    by Magdalena Prynda, Mikołaj Mazur, Patrycja Doroz, Olga Odrzywolska, Ali Aboud, Adrian Dyląg, Wojciech Niemczyk

    People with autism spectrum disorder (ASD) often face many difficulties when trying to get dental care. These challenges are caused by their unique health needs, behavior differences, and trouble with communication. Many individuals with ASD need help from caregivers to keep up with daily routines like brushing and flossing, which may not always be done regularly. They may also have picky eating habits that increase the risk of tooth decay. In some cases, they may not be able to tell others when they are in pain or need help with a dental problem. Going to the dentist can be very stressful for people with ASD. The loud sounds, bright lights, and unfamiliar tools in dental offices can cause fear or anxiety. Some dental clinics are not set up to support patients with special needs, which makes the visit even harder. Also, many dentists and staff members do not have enough training to care for patients with autism. This paper aims to look at the problems people with ASD face in getting dental care and to suggest ways to make dental visits easier and better for them. Improving access and comfort can help people with ASD have healthier teeth and a better quality of life.


  • Application of i-PRF in dentistry

    by Wojciech Niemczyk, Stanisław Niemczyk, Olga Odrzywolska, Patrycja Doroz, Dawid Hochuł, Kaja Zawadzka

    Injectable platelet-rich fibrin (i-PRF) is a novel platelet concentrate that has been employed in dentistry with the objective of promoting tissue regeneration and healing. In contrast to platelet-rich plasma (PRP), i-PRF is more straightforward to handle, more cost-effective, and free from anticoagulants, which reduces biochemical alterations. The i-PRF procedure was developed in 2014 by adjusting the centrifugation forces. The resulting product remains in a liquid state for approximately 15 minutes, gradually transforming into a growth factor-rich clot that releases continuously over 10-14 days. It has demonstrated efficacy in a range of dental applications. In periodontology, i-PRF is an effective treatment for periodontitis, enhancing gingival thickness and reducing inflammation, plaque, and recession. Furthermore, it enhances the outcomes of periodontal regenerative surgery and lichen planus treatment. In oral surgery, i-PRF has been shown to facilitate bone regeneration, fistula resolution, and sinus augmentation. Orthodontic studies have indicated that i-PRF accelerates tooth movement and bone remodeling. However, osteomicroperforation remains more effective for some treatments. A limited number of endodontic studies have indicated that i-PRF may support revascularisation and periapical healing. In conclusion, i-PRF's regenerative capabilities, anti-inflammatory and antimicrobial properties offer significant potential in dentistry, and further exploration and application is therefore warranted.